Book contents
- Neuromuscular Disease: A Case-Based Approach
- Neuromuscular Disease
- Copyright page
- Contents
- Contributors
- Foreword
- Preface to 2nd Edition
- Part I Evaluation and Treatment of Patients with a Neuromuscular Disorder
- Chapter 1 Neuromuscular Diseases: Anterior Horn Cell Disorders, Peripheral Neuropathies, Neuromuscular Junction Disorders, Myopathies
- Chapter 2 History Taking and Clinical Examination
- Chapter 3 Differential Diagnoses by Presenting or Prominent Clinical Feature
- Chapter 4 Electrodiagnostic Studies
- Chapter 5 Imaging
- Chapter 6 Muscle and Nerve Pathology
- Chapter 7 Genetic Testing
- Chapter 8 Management
- Part II Neuromuscular Cases
- Video legends
- Index
- References
Chapter 7 - Genetic Testing
from Part I - Evaluation and Treatment of Patients with a Neuromuscular Disorder
Published online by Cambridge University Press: 29 November 2024
- Neuromuscular Disease: A Case-Based Approach
- Neuromuscular Disease
- Copyright page
- Contents
- Contributors
- Foreword
- Preface to 2nd Edition
- Part I Evaluation and Treatment of Patients with a Neuromuscular Disorder
- Chapter 1 Neuromuscular Diseases: Anterior Horn Cell Disorders, Peripheral Neuropathies, Neuromuscular Junction Disorders, Myopathies
- Chapter 2 History Taking and Clinical Examination
- Chapter 3 Differential Diagnoses by Presenting or Prominent Clinical Feature
- Chapter 4 Electrodiagnostic Studies
- Chapter 5 Imaging
- Chapter 6 Muscle and Nerve Pathology
- Chapter 7 Genetic Testing
- Chapter 8 Management
- Part II Neuromuscular Cases
- Video legends
- Index
- References
Summary
Driven by technological advances, an ever-increasing number of genes and mutations are implicated in neuromuscular diseases. This has led to revised classifications of neuromuscular diseases and expanding phenotypic spectra related to single genes. As a result, gene-targeted therapies are emerging. Combined with the reduction in costs of genome sequencing, genetic testing plays an increasingly important role in the diagnostic process of neuromuscular diseases. Nevertheless, caution is warranted since results of genome sequencing can be challenging regarding the interpretation of the results. Here we discuss general principles that aid the efficient use of genetic testing that may improve the interpretation of results (see Table 7.1).
Keywords
- Type
- Chapter
- Information
- Neuromuscular DiseaseA Case-Based Approach, pp. 52 - 56Publisher: Cambridge University PressPrint publication year: 2024